Minerva Neurosciences, Inc - Common Stock — 재무제표 (NASDAQ:NERV) | MetaTrader

전체 차트 열기 Full chart

뉴스

All You Need to Know About Minerva Neurosciences (NERV) Rating Upgrade to Buy

Minerva Neurosciences (NERV) Loses 37.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

미네르바 뉴로사이언스, 임상 설계 개선에 H.C. 웨인라이트 목표가 상향

H.C. Wainwright raises Minerva Neurosciences price target on trial design

Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript

미네르바 뉴로사이언스, 정신분열증 전문가 이사회 임명

Minerva Neurosciences appoints schizophrenia expert to board of directors

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.47%

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial - Minerva Neurosciences (NASDAQ:NERV)

미네르바 뉴로사이언스, 2억 달러 자금 확보 후 주가 급등

Minerva Neurosciences stock soars after securing $200 million financing

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - American Rebel Holdings (NASDAQ:AREB), Beyond Meat (NASDAQ:BYND)